期刊文献+

中西医结合治疗尿毒症心肌病疗效分析 被引量:2

Efficacy analysis of uremic cardiomyopathy treated with integrated traditional Chinese and western medicine
下载PDF
导出
摘要 目的:探讨中西医联合治疗尿毒症心肌病的疗效。方法:50例尿毒症心肌病患者随机分为观察组与对照组,各25例,两组均接受血液透析治疗,对照组予以常规西医治疗,观察组在对照组的基础上加用中药真武汤加减治疗,比较两组疗效。结果:治疗后两组的心功能均显著改善,观察组显著优于对照组(P<0.05);观察组的猝死率为8%,复发率为12.0%,均较对照组的16%、32%显著降低(P<0.05)。结论:中西医结合治疗尿毒症心肌病可改善患者的心功能、贫血状态及生活质量,疗效持续时间长,值得推广应用。 Objective:To investigate the efficacy of uremic cardiomyopathy treated with integrated traditional Chinese and western medicine.Methods:50 cases of uremic cardiomyopathy patients were randomly divided into an observation group and a control group, 25 cases in each. Both groups were given hemodialysis treatment. The control group was treated with conventional western medicine, while the observation group was treated with Traditional Chinese Medicine Zhenwu decoction on the basis of the treatment for the control group, the efficacy of two groups were compared. Results:After treatment, the cardiac functions in the two groups were significantly improved, and the condition of observation group was significantly better than that of the control group(P〈0.05);the sudden death rate of the observation group was 8%, the recurrence rate was 12%, significantly lower than 16%, 32% in the control group(P〈0.05).Conclusion:Traditional Chinese Medicine combined western medicine in the treatment of uremic cardiomyopathy can improve the conditions of cardiac function, anemia and quality of life with long time effects which is worthy of application.
作者 李睿
出处 《中医临床研究》 2014年第15期72-73,共2页 Clinical Journal Of Chinese Medicine
关键词 中西医结合 尿毒症心肌病 临床疗效 Chinese traditional medicine combined western medicine Uremic cardiomyopathy Clinical efficacy
  • 相关文献

参考文献5

二级参考文献48

  • 1刘淑娟,黄春林.中西医结合治疗尿毒症心肌病的思路与方法[J].新中医,2005,37(3):3-5. 被引量:3
  • 2白洁,张国辉.醛固酮受体拮抗剂在扩张型心肌病中的应用[J].心血管病学进展,2006,27(6):767-769. 被引量:4
  • 3唐川苏,罗贵全,周明刚.倍他乐克治疗扩张型心肌病65例临床观察[J].中国现代医学杂志,2007,17(1):119-121. 被引量:11
  • 4申林,张贤贤.中西医结合治疗尿毒症疗效观察[J].中国误诊学杂志,2007,7(16):3764-3765. 被引量:3
  • 5张九芝 白光辉.尿毒症心肌病的诊治进展.中外健康文摘(医学理论与实践),2008,4(1):25-26.
  • 6Silverbei DG,Wexler D,Blum M,et al.The association between congestive heart failure and chronic renal disease[J].Curr Opin Nephrol Hyperten,2004,13(2):163.
  • 7Fujimoto N, Iseki K, Tokuyama K, et al. Significance of coronary artery calcification score(CACS) for the detection of coronary artery disease in chronic dialysis patients. Clin Chim Acta, 2006, 367(1 -2) :98 - 102.
  • 8Pozzoni P, Del Vecchio L, Pontoriero G, et al. Long - teim out- come in hemodialysis : morbidity and mortality. J Nephrol, 2004, 17 ( Suppl 8 ) : S87 - S95.
  • 9Foley RN, Parfrey PS, Hamett JD, et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol, 1995,5(12) :2024 - 2031.
  • 10Nayak SG, Satisk R, Gokulnath. An unusual toxic cause of hemo lyticuremic syndrome. J Toxicol Sci, 2007,32 ( 2 ) : 197 - 199.

共引文献31

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部